Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
 Papers of the Week
Papers:  
Keywords:   any keywords all keywords
Author:     Select Author  (e.g. Doe, J)
Comments By:     Select Commentator
Journal:     Select Journal
Pub Date:   From
  To    
Limited To:   Commented    ARF Recommends    Milestone
Sort By:     Show:  
   
 Search Results:
Week of 1-7 February 2013
1 to 25 of 170 results
Back   of 7  Next
Wise-Scira O, Dunn A, Aloglu AK, Sakallioglu IT, Coskuner O. Structures of the E46K Mutant-Type α-Synuclein Protein and Impact of E46K Mutation on the Structures of the Wild-Type α-Synuclein Protein. ACS Chem Neurosci. 2013 Jan 30; PubMed Abstract
separator
Wise-Scira O, Aloglu AK, Dunn A, Sakallioglu IT, Coskuner O. Structures and Free Energy Landscapes of the Wild-Type and A30P Mutant-Type α-Synuclein Proteins with Dynamics. ACS Chem Neurosci. 2013 Jan 30; PubMed Abstract
separator
Silva D, Chioua M, Samadi A, Agostinho P, Garção P, Lajarín-Cuesta R, de los Ríos C, Iriepa I, Moraleda I, Gonzalez-Lafuente L, Mendes E, Pérez C, Rodríguez-Franco MI, Marco-Contelles J, Carmo Carreiras M. Synthesis, Pharmacological Assessment, and Molecular Modeling of Acetylcholinesterase/Butyrylcholinesterase Inhibitors: Effect against Amyloid-β-Induced Neurotoxicity. ACS Chem Neurosci. 2013 Feb 4; PubMed Abstract
separator
Czapski GA, Maruszak A, Styczynska M, Zekanowski C, Safranow K, Strosznajder JB. Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer's disease. Acta Neurobiol Exp (Wars). 2012;72(4):397-411. PubMed Abstract
separator
Ziemka-Nalecz M, Zalewska T. Endogenous neurogenesis induced by ischemic brain injury or neurodegenerative diseases in adults. Acta Neurobiol Exp (Wars). 2012;72(4):309-24. PubMed Abstract
separator
Shinohara M, Petersen RC, Dickson DW, Bu G. Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation. Acta Neuropathol. 2013 Jan 31; PubMed Abstract
separator
Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE, Yen SH, Dickson DW. Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol. 2013 Jan 31; PubMed Abstract
separator
Grinberg LT, Wang X, Wang C, Sohn PD, Theofilas P, Sidhu M, Arevalo JB, Heinsen H, Huang EJ, Rosen H, Miller BL, Gan L, Seeley WW. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. Acta Neuropathol. 2013 Jan 31; PubMed Abstract
separator
Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R, Peterson M, Siddique N, Geula C, Siddique T, Mesulam M. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol. 2013 Feb 3; PubMed Abstract
separator
Mori K, Lammich S, Mackenzie IR, Forné I, Zilow S, Kretzschmar H, Edbauer D, Janssens J, Kleinberger G, Cruts M, Herms J, Neumann M, Van Broeckhoven C, Arzberger T, Haass C. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013 Feb 5; PubMed Abstract
separator
Hochfeld WE, Lee S, Rubinsztein DC. Therapeutic induction of autophagy to modulate neurodegenerative disease progression. Acta Pharmacol Sin. 2013 Feb 4; PubMed Abstract
separator
Leal S, Yassa MA. Perturbations of Neural Circuitry in Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Ageing Res Rev. 2013 Feb 1; PubMed Abstract
separator
Parrella E, Maxim T, Maialetti F, Zhang L, Wan J, Wei M, Cohen P, Fontana L, Longo VD. Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model. Aging Cell. 2013 Jan 30; PubMed Abstract
separator
Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust WJ, Weiner MW, Jack CR, Alzheimer's Disease Neuroimaging Initiative. Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H, Pentzek M, Riedel-Heller SG, Luck T, Fuchs A, Weyerer S, Werle J, van den Bussche H, Scherer M, Maier W, Wagner M, German Study on Aging, Cognition and Dementia in Primary Care Patients. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM, Alzheimer's Disease Neuroimaging Initiative. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, Ashford JW. Improving dementia care: The role of screening and detection of cognitive impairment. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DM, AV45-A11 study group. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB, Translational Outpatient Memory Clinic Working Group, Alzheimer's Disease Neuroimaging Initiative. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimers Dement. 2013 Jan 30; PubMed Abstract
separator
Lane RF, Dacks PA, Shineman DW, Fillit HM. Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery. Alzheimers Res Ther. 2013 Feb 4;5(1):5. PubMed Abstract
separator
Suttkus A, Rohn S, Jäger C, Arendt T, Morawski M. Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis. 2012;1(2):122-9. PubMed Abstract
separator
Wojtas A, Heggeli KA, Finch N, Baker M, Dejesus-Hernandez M, Younkin SG, Dickson DW, Graff-Radford NR, Rademakers R. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis. 2012;1(1):107-18. PubMed Abstract
separator
Le MN, Kim W, Lee S, McKee AC, Hall GF. Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model. Am J Neurodegener Dis. 2012;1(3):316-33. PubMed Abstract
separator
Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI. Therapeutic application of melatonin in mild cognitive impairment. Am J Neurodegener Dis. 2012;1(3):280-91. PubMed Abstract
separator
O'Hagan TS, Wharton W, Kehoe PG. Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. Am J Neurodegener Dis. 2012;1(3):266-79. PubMed Abstract
1 to 25 of 170 results
Back   of 7  Next
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Forum Calendar

See our latest Webinar: Neuroinflammation—A Prelude to Alzheimer's?

Check out our recent Webinar: International Student Workshop on AD.

See our past Webinar: Latest γ-secretase Substrate Involved in Synaptic Stability, Autism?

AlzGene
PDGene
SZGene
MSGene
ALSGene
An up-to-date collection of all published genetic association studies.
AlzRisk: An AD Epidemiology Database
The AlzRisk Epidemiology Database provides a publicly available collection of published studies on the impact of putative environmental risk factors and protective factors related to Alzheimer disease in longitudinal cohort studies.
Alzheimer's Research & Therapy

Announcing Alzheimer's Research & Therapy, a new online peer-reviewed journal which publishes open access research articles of outstanding quality in Alzheimer's research.
Alzheimer's Research & Therapy
Journal of Alzheimer's Disease
Journal of Degeneration and Regeneration
From basic clinical research to case studies. View web site.
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad